Americans now say they approve of free trade by 64%-27%, a margin of better than two to one. That's up from 57%-37% early in Trump's presidency, and 51%-41% near the end of...Politicsread more
The yield on the benchmark 10-year Treasury note briefly fell below the 2-year rate on Wednesday, a phenomenon in the bond market known as yield curve inversion, which is...Marketsread more
The MacBook Pro recall and its subsequent ban from flights underscores the increasing brand risk from problems with lithium-ion batteries.Technologyread more
Experts say the timing of Amazon executives' contributions to Rep. David Cicilline likely reflect the company's heightened urgency over growing regulatory scrutiny.Technologyread more
CNBC combed through Wall Street research to see which stocks are still a buy after their earnings reports.Marketsread more
Despite aggressive strides, Waymo needs one thing before their self-driving cars become a seriously useful transportation system: people. We talked to the ones closest to it.Technologyread more
Coinbase security chief Philip Martin explains, "Possession of a key is possession of your currency. What that means is that you can't revoke a cryptocurrency key, if that key...Technologyread more
Fraud investigator Harry Markopolos' accusations extended beyond GE's management to actuaries, auditors and analysts who he claims overlooked billions in liabilities.Marketsread more
The Supreme Court could strike down the constitutionality of the Consumer Financial Protection Bureau, an agency Elizabeth Warren has likened to her child and which Justice...2020 Electionsread more
Bianco Research's James Bianco suggests Wall Street is desperately looking for a signal that a 50 basis point cut is coming next month.Trading Nationread more
The company's S-1 lays the groundwork for what is widely expected to be one of the largest initial public offerings of the year, second only to Uber's IPO in May. It's also...Technologyread more
A non-psychoactive cannabis compound more commonly known as CBD is "poised to flourish" thanks to the 2018 Farm Bill, signed into law by President Donald Trump.
That's according to analysts at Canaccord Genuity who have published a list of their favorite stocks as the cannabis industry takes off.
The 2018 Farm Bill has removed all cannabis fibre products with less than a 0.3 percent concentration of the psychoactive element tetrahydrocannabinol ( "THC") from the Controlled Substances Act.
That means it is now legal to manufacture, distribute and sell hemp-derived cannabidiol (CBD) anywhere in the United States. CBD is viewed by many to have medical benefits, providing relief from everything from pain to depression and anxiety.
In a note Wednesday, Canaccord Genuity identified these stocks as plays for investors looking to take advantage of firms that market hemp-derived CBD products.
• Charlotte's Web Holdings, Inc. (CWEB-CSE | BUY; C$21.00 PT)
• Canopy Growth Corporation (WEED-TSE | SPECULATIVE BUY; C$50.00 PT)
• Curaleaf Holdings, Inc. (CURA-CSE | SPECULATIVE BUY; C$13.00 PT)
• Liberty Health Sciences Inc. (LHS-CSE | SPECULATIVE BUY, C$2.00 PT)
• 1933 Industries, Inc. (TGIF-CSE | SPECULATIVE BUY, C$0.70 PT)
• DionyMed Brands, Inc. (DYME-CSE | SPECULATIVE BUY, C$5.50 PT)
• KushCo. Holdings, Inc. (KSHB-OTC | SPECULATIVE BUY, US$7.50 PT)
• MJardin Group, Inc. (MJAR-CSE | SPECULATIVE BUY, C$9.00 PT)
Despite the passing of the Farm Bill, legal ambiguities have remained as the U.S. Food and Drug Administration (FDA) has maintained its stance that it is unlawful to sell CBD as a dietary supplement.
Canaccord's North American equity research team said despite this confusion it had noted products already being sold through Safeway in some U.S. states and that other retailers would likely follow this year.
"While the FDA's stance has added some initial caution by retailers looking to enter the CBD space, we believe this to be transient, and expect many mass market retailers to begin distributing CBD products over the course of 2019," the note read.
Hemp comes from the same cannabis plant that produces marijuana. But while marijuana has both cannabidiol (CBD and tetrahydrocannabinol (THC)), hemp, is produced with nearly 100 percent non-psychoactive CBD.
Canaccord say cultivation of hemp in the United States began in the early 1600s when English settlers grew the plant to produce rope, sails and clothes.
By the 1700s many American colonies legally required settlers to produce hemp as a raw material to build warships and trading vessels.
A number of restrictions were placed on Marijuana products throughout the first half of the twentieth century and in 1970, hemp became illegal as President Richard Nixon labelled it a Schedule 1 drug on the Controlled Substances Act.
CNBC 's Jim Cramer also expects to see cannabidiol related stocks grow in 2019, describing it as a "massive opportunity."
"That's going to give the CBD market a major boost," Cramer said noting that after the farm bill passed Canadian firm, Canopy Growth, announced it would be entering the United States market.
NOW WATCH: Cramer's top 5 pot predictions for 2019